Announced Tue, 7 Apr · 15:01 IST
Company Confirms It Does Not Qualify as Large Corporate
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+3.0%1-day move
₹211.05
prior close
₹207.55
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0-1.7+0.7—+3.0-0.1-1.9-0.5+1.7+6.5-0.4+5.2-2.4+31.7
Up moveDown movePending
AI summary
Samrat Pharmachem Limited has submitted a declaration to BSE confirming it does not qualify as a 'Large Corporate' under SEBI's circular dated November 26, 2018. This is a routine annual compliance filing under Annexure A, where companies either confirm or deny Large Corporate status. The declaration is signed by Company Secretary Nishant Kankaria and CFO Rajesh Mehta on April 7, 2026.
Likely market impact
Routine compliance filing with no material impact on shareholders, stock price, or business operations.